Global /United States /Healthcare /Biotechnology /WHWK

Whitehawk Therapeutics, Inc.

WHWK

• NASDAQ: WHWK • Delayed

4.03USD -2.4%

As of 14 June 2026, Whitehawk Therapeutics, Inc. has a market cap of $190.2M USD, ranking #21412 globally and #3478 in the United States. It ranks #1915 in the Healthcare sector, and #373 in the Biotechnology industry.

Global Rank

21412

Country Rank

3478

Sector Rank

1915

Industry Rank

373

Key Stats

Market Cap

$190.2MUSD

Enterprise Value

$47.57MUSD

Revenue (TTM)

$7.15MUSD

EBITDA (TTM)

-$114.32MUSD

Net Income (TTM)

-$20.6MUSD

Profit Margin

-288%

PS Ratio

27.0

PB Ratio

1.4

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

David Lennon open_in_new

Employees

Founded

2007

Website

ir.whitehawktx.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.4%	-1.7%	31%	49%	71%	71%	185%	-48%	-99%

News

WHWK Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	WHWK Whitehawk Therapeutics Inc ISIN: US00032Q1040 Shares Out.: Shares Outstanding: 49.453M¹ Shares Float: 29.994M² TV: TradingView: NASDAQ: WHWK SA: Stock Analysis: NASDAQ: WHWK YF: Yahoo Finance: WHWK GF: Google Finance: NASDAQ: WHWK NQ: NASDAQ: WHWK BA: Barron's: WHWK MS: Morningstar: XNAS: WHWK	4.03 USD	TV: TradingView: NASDAQ: WHWK SA: Stock Analysis: NASDAQ: WHWK YF: Yahoo Finance: WHWK GF: Google Finance: NASDAQ: WHWK NQ: NASDAQ: WHWK BA: Barron's: WHWK MS: Morningstar: XNAS: WHWK

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 96K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 84K%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 14K%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 14K%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 13K%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 9K%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 25K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 23K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 22K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 22K%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 15K%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 13K%	-	Germany

chevron_leftBack